| Autor: |
Colby R; Rebecca Colby practices at Northstate Cardiology Consultants in Chico, Calif. Holly Geyer practices hospital internal medicine at the Mayo Clinic in Phoenix, Ariz. The authors have disclosed no potential conflicts of interest, financial or otherwise., Geyer H |
| Jazyk: |
angličtina |
| Zdroj: |
JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2017 Nov; Vol. 30 (11), pp. 23-26. |
| DOI: |
10.1097/01.JAA.0000524713.17719.c8 |
| Abstrakt: |
Amiodarone is widely used to prevent ventricular and supraventricular dysrhythmias but has a number of toxicities. One of the most devastating adverse reactions to this drug is pulmonary toxicity, which can present in a myriad of different ways. Toxicity is difficult to diagnose because many of its features also are seen in nontoxic patients. This article reviews the pathophysiology, presentation, diagnosis, and treatment of amiodarone-induced pulmonary toxicity. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
